This program is currently between intakes. N-GAPP runs approximately annually. The 2026 cycle has now closed: LOI deadline was April 22, 2026; full proposals were due June 22, 2026. Confirm on the official site ↗
Updated June 2026 · Verified against Genome Canada guidelines
Milestone-Based Est. 2012
Grant Federal Between Intakes

National Genomic Applications Partnership Program (N-GAPP)

Genome Canada
Maximum Funding
$300,000–$2,000,000
Between intakes — 2026 LOI cycle closed April 22, 2026; full proposals due Ju...
Visit Official Program →
Difficulty
Hard
Payment
Milestone-Based
Trend
Stable
First-Timers
Co-Funding
33%
National Genomic Applications Partnership Program (N-GAPP) provides up to $300,000–$2,000,000. Funds public-private R&D partnerships to commercialize Canadian genomics and biotech innovations. The program covers up to 33% of eligible costs. Between intakes — 2026 LOI cycle closed April 22, 2026; full proposals due June 22, 2026 now past. Next LOI expected April 2027.. (As of March 2026, verified against Genome Canada program guidelines) Approval odds: ~20% (GrantCompass analysis)
Eligibility check

Can you win this grant?

Get your instant eligibility verdict plus a head start on the application. Free, no account needed.

Takes about 20 seconds. We use this grant’s real eligibility rules.

Eligibility & Details

What this program funds and who can apply

Free

Program Description

Funds public-private R&D partnerships to commercialize Canadian genomics and biotech innovations. Genome Canada provides up to one-third of total project costs, with industry and other sources covering the remainder. Projects must be defined by an industry 'Receptor' partner around a real market need with genomics innovation as the core solution.

Eligibility Requirements

  • Projects must be co-led by a Canadian academic researcher and a Canadian for-profit enterprise (Receptor)
  • Receptor must define the commercial opportunity
  • Canadian-domiciled for-profit entities as Receptors
  • Project must address a real commercial need identified by industry
  • Innovation must be genomics-based or biotechnology-driven
Provinces
Industries
Biotechnology Life Sciences Healthcare Agriculture Food Beverage Environmental Conservation +1 more
Business Stage
Growth Expansion Established

Quick Assessment

Difficulty
Hard
Competition
High
Est. Hours
80h
First-Timer
Not rated

Funding Details

Amount
$300,000–$2,000,000
Type
Grant
Level
Federal
Co-Funding
Up to 33% of eligible costs
Deadline
Between intakes — 2026 LOI cycle closed April 22, 2026; full proposals due June 22, 2026 now past. Next LOI expected April 2027.

Program Scorecard

Competition, effort, and approval at a glance

Hybrid
Competition
High
Effort
~80 hours
Approval
Competitive
Approval Rate
~20%
Accessibility
--/5
Competition
--/5
Premium Know if this program is worth your 40 hours — before you start the application.
Know if this grant is yours to win before you spend 40 hours writing it
Approval likelihood, realistic amounts, competition level, and what winners look like
A consultant charges $2,000–$5,000 for one application. Premium is $39/mo — every program.
Get Premium — $39/mo Every grant · Application workspace · 30-day money-back
or just this Playbook — $19 one-time
What's in this Playbook

Everything you need to win N-GAPP

Not a marketing summary. The actual checklist, intel, and stack strategy reviewers look for.

$19 covers this one grant. $39/mo covers every grant — plus the workspace that walks you through each application.

Applying for N-GAPP? Our Financial Projections Model ($29) covers the cost-share, matching-fund, and cash-flow math reviewers want to see. Or get all 4 templates in the Founder Pack ($59 · saves $27) →

How to Win

Insider tips, common pitfalls, and what successful applicants look like

Premium
Insider Tip

The single most important factor is a credible, committed industry Receptor — not the research quality. Contact your regional Genome Centre before writing the LOI for free pre-submission feedback. Receptor cash (not in-kind) is weighted most heavily.

Premium See what trips up most applicants for this program — and how to avoid it.

Success Profile

Canadian biotech, agri-food, or health sciences company with a specific technology gap that genomics can solve, partnered with an academic lab. Company should have commercial revenue and be prepared to invest cash.

Premium See what successful applicants for this program actually look like.

Evaluation Criteria

Three-stage evaluation: (1) LOI assessed on innovation quality, commercial potential, industry Receptor commitment, and alignment with Genome Canada strategic priorities; (2) Full proposal peer-reviewed for scientific merit, commercial viability, team qualifications, budget justification, and IP/commercialization plan; (3) Pitch presentation to review panel. Industry Receptor credibility and cash commitment are weighted most heavily — the commercial pull must be genuine and well-defined.

Premium See exactly what reviewers score on — so you know where to focus.
Don’t waste 80 hours on a preventable rejection
Common rejection pitfalls, what winners look like, and exactly what reviewers score on
Paid grant writers quote $2,000–$5,000 per program. Premium covers all 650+ for $39/mo.
Get Premium — $39/mo Every grant · Application workspace · 30-day money-back
or just this Playbook — $19 one-time

Application Playbook

Step-by-step process, required documents, and expenses

Premium 7 steps 6 docs

Application Steps

1 Contact Regional Genome Centre Reach out to your regional Genome Centre (Genome Alberta, Genome BC, Ontario Genomics, Genome Quebec, Genome Prairie, Genome Atlantic) well before the LOI deadline. They provide free pre-submission feedback and can connect you with potential partners.
2 Identify Industry Receptor The most critical step. Identify a Canadian for-profit company with a genuine commercial need that genomics can solve. The Receptor must define the project around a real market opportunity — not the other way around.
3 Pair with Academic Researcher The project must be co-led by a Canadian academic researcher at an eligible institution. The researcher provides the genomics expertise; the Receptor provides the commercial direction. Regional Genome Centres can facilitate introductions.
4 Submit Letter of Intent (LOI) Submit LOI through your regional Genome Centre by the deadline. The 2026 LOI deadline was April 22, 2026. Next cycle LOI expected ~April 2027.
5 Full Proposal (if invited) Invited applicants submit a detailed full proposal (for the 2026 cycle this was due June 22, 2026; the next cycle’s proposal is expected ~June 2027) covering technical methodology, commercialization strategy, market validation, team qualifications, detailed budget, and IP plan.
6 Pitch Presentation Shortlisted teams present to a review panel. Industry Receptor engagement and commercial credibility are heavily scrutinized at this stage.
7 Funding Decision and Project Launch Funding decisions announced approximately Q4 each year. 2026 cycle projects start January 2027; 2027 cycle projects expected to start January 2028.

Required Documents 6

LOI through regional Genome Centre
Full application with research methodology
Budget showing Genome Canada (max 1/3), industry cash, other sources
Industry partner commitment letter
CVs of lead team
IP and commercialization plan

Eligible Expenses 9

  • Salaries and benefits for research personnel (academic and industry)
  • Graduate student and postdoctoral fellow stipends
  • Materials, consumables, and laboratory supplies
  • Equipment purchases essential to the project
  • Subcontractor fees for specialized services
  • Travel for project-related collaboration
  • Intellectual property protection costs
  • Knowledge translation and dissemination activities
  • Project management and coordination costs

Ineligible Expenses 5

  • Indirect costs or overhead already covered by institutional support
  • Core operating expenses of the company unrelated to the project
  • Capital infrastructure or building construction
  • Activities completed before the project start date
  • Lobbying or government relations activities

Intake Periods

N-GAPP runs approximately annually. The 2026 cycle has now closed: LOI deadline was April 22, 2026; full proposals were due June 22, 2026. Projects from the 2026 cycle are expected to start January 2027. The next LOI cycle (N-GAPP 2027) is expected approximately April 2027 — contact your regional Genome Centre (Genome Alberta, Ontario Genomics, Genome Quebec, etc.) for confirmation. Regional GAPP (R-GAPP) runs through individual Genome Centres on separate timelines.

Deadline Notes

N-GAPP 2026 cycle: LOI due April 22, 2026 (past); full proposals due June 22, 2026 (past); projects start January 2027. Next cycle (N-GAPP 2027) LOI expected April 2027. Contact your regional Genome Centre for confirmation. Contact your regional Genome Centre (Genome Alberta, Ontario Genomics, Genome Quebec, etc.) before writing the LOI.

Open Application Portal →

Ineligible Organizations

  • Companies without Canadian domicile or incorporation
  • Non-profit organizations acting as sole industry Receptor
  • Academic institutions applying without an industry Receptor partner
  • Companies with no genuine commercial application for genomics innovation
  • Foreign companies without a Canadian subsidiary
Premium Get the step-by-step application guide — documents, timeline, and what to prepare.

Funding Stack Strategy

Compatible programs, clawback risk, and combined funding potential

Premium 5 partners

Compatible Programs

NRC-IRAP SR&ED Tax Credits NSERC Alliance Grants BDC Venture Financing Provincial Biotech Grants
Combined Funding Potential See your total funding potential

Clawback Risk

Low Risk
Premium See which programs combine with this one — and how much more you could get.
Stack this with 5 compatible programs to multiply your funding
Stacking amounts, clawback details, government stacking limits, and tax implications
One avoided clawback typically pays for years of Premium.
Get Premium — $39/mo Every grant · Application workspace · 30-day money-back
or just this Playbook — $19 one-time

How N-GAPP Compares

Side-by-side with similar programs

Free
Program Amount Difficulty Payment Deadline
National Genomic Applications Partner... $300,000–$2,000,000 Hard Milestone-Based Between intakes — 2026...
Strategic Response Fund (formerly Str... Up to $50 million Hard Mixed (Advance + Reimb.) Ongoing — continuous...
CanExport SMEs Up to $50,000 Moderate Mixed (Advance + Reimb.) Applications accepted...
Digital Technology Supercluster Up to $5 million Hard Reimbursement Open — Call for...
Ontario Innovation Tax Credit Up to 8% tax credit Moderate Tax Credit Offset Ongoing

Related Programs

Other programs you might be eligible for

Free

Frequently Asked Questions

Quick answers to the questions founders most often ask about N-GAPP

Free
Can sole proprietors apply as the Receptor?
No. Receptors must be incorporated Canadian for-profits. Sole proprietors cannot be the industry partner; they must form a corporation to apply.
What's the typical project size?
Realistic total project costs: $1.5M–$4.5M. Genome Canada funds 1/3 ($500k–$1.5M), requiring industry to cover 2/3 with cash (not in-kind).
When are decisions made?
The 2026 cycle is now closed — LOIs were due April 22, 2026 and full proposals were due June 22, 2026. Decisions for the 2026 cycle are expected by late 2026, with projects starting January 2027. The next LOI cycle is expected approximately April 2027; contact your regional Genome Centre to confirm.
Why do most applications fail?
Weak industry Receptor commitment (e.g., passive involvement), or failing to meet the 1/3 funding rule (Genome Canada can't fund more than 1/3 of total project costs).
Can I stack this with SR&ED?
Yes. SR&ED claims apply to eligible R&D costs not covered by N-GAPP. Industry partners can claim SR&ED on their share of project costs.

Browse More Funding